BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grünwald V, Eberhardt B, Bex A, Flörcken A, Gauler T, Derlin T, Panzica M, Dürr HR, Grötz KA, Giles RH, von Falck C, Graser A, Muacevic A, Staehler M. An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma. Nat Rev Urol 2018;15:511-21. [PMID: 29904105 DOI: 10.1038/s41585-018-0034-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Ji L, Zhang W, Huang J, Tian J, Zhong X, Luo J, Zhu S, He Z, Tong Y, Meng X, Kang Y, Bi Q. Bone metastasis risk and prognosis assessment models for kidney cancer based on machine learning. Front Public Health 2022;10. [DOI: 10.3389/fpubh.2022.1015952] [Reference Citation Analysis]
2 Seker NS, Canaz F, İnan U, Kavak M, Bülbül Ö. Metastatik Kemik Tümörlerinin Retrospektif Değerlendirmesi. Düzce Tıp Fakültesi Dergisi 2022. [DOI: 10.18678/dtfd.1129573] [Reference Citation Analysis]
3 Bazzocchi A, Aparisi Gómez MP, Taninokuchi Tomassoni M, Napoli A, Filippiadis D, Guglielmi G. Musculoskeletal oncology and thermal ablation: the current and emerging role of interventional radiology. Skeletal Radiol 2022. [DOI: 10.1007/s00256-022-04213-3] [Reference Citation Analysis]
4 Udovicich C, Callahan J, Bressel M, Ong WL, Perera M, Tran B, Azad A, Haran S, Moon D, Chander S, Shaw M, Eapen R, Goad J, Lawrentschuk N, Murphy DG, Hofman M, Siva S. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma. European Urology Open Science 2022;44:60-68. [DOI: 10.1016/j.euros.2022.08.001] [Reference Citation Analysis]
5 Ortiz-cruz E, García-mauriño Peñín C, Moriel-garceso D, Peleteiro Pensado M, Barrientos Ruiz I, Redondo Sánchez A, Pozo-kreilinger J, Belinchón-olmeda B, Tapia-viñe M. [Translated article] Oligometastases in oncological orthopaedic surgery. Our experience. Revista Española de Cirugía Ortopédica y Traumatología 2022;66:T389-T396. [DOI: 10.1016/j.recot.2022.07.009] [Reference Citation Analysis]
6 Ortiz-cruz EJ, García-mauriño Peñín C, Moriel-garceso DJ, Peleteiro Pensado M, Barrientos Ruiz I, Redondo Sánchez A, Pozo-kreilinger JJ, Belinchón-olmeda B, Tapia-viñe M. Oligometástasis en la cirugía ortopédica oncológica. Nuestra experiencia. Revista Española de Cirugía Ortopédica y Traumatología 2022;66:389-396. [DOI: 10.1016/j.recot.2021.06.005] [Reference Citation Analysis]
7 Onal C, Guler OC, Hurmuz P, Yavas G, Tilki B, Oymak E, Yavas C, Ozyigit G. Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study. Strahlenther Onkol 2022. [PMID: 35695908 DOI: 10.1007/s00066-022-01962-x] [Reference Citation Analysis]
8 Motzer RJ, Powles T, Burotto M, Escudier B, Bourlon MT, Shah AY, Suárez C, Hamzaj A, Porta C, Hocking CM, Kessler ER, Gurney H, Tomita Y, Bedke J, Zhang J, Simsek B, Scheffold C, Apolo AB, Choueiri TK. Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial. The Lancet Oncology 2022. [DOI: 10.1016/s1470-2045(22)00290-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Chen L, Sun L, Yao J, Zhao B, Shao Z, Chen X. Robust Silk Protein Hydrogels Made by a Facile One-Step Method and Their Multiple Applications. ACS Appl Bio Mater 2022. [PMID: 35608071 DOI: 10.1021/acsabm.2c00354] [Reference Citation Analysis]
10 Sethakorn N, Heninger E, Sánchez-de-Diego C, Ding AB, Yada RC, Kerr SC, Kosoff D, Beebe DJ, Lang JM. Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment. Cancers (Basel) 2022;14:757. [PMID: 35159026 DOI: 10.3390/cancers14030757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Ong S, Bagguley D, Rajarubendra N, Lawrentschuk N. Diagnosis of bone metastases in urological malignancies—an update. Bone Cancer 2022. [DOI: 10.1016/b978-0-12-821666-8.00062-1] [Reference Citation Analysis]
12 Turner BM, Hicks DG. The histopathology of skeletal metastases. Bone Cancer 2022. [DOI: 10.1016/b978-0-12-821666-8.00036-0] [Reference Citation Analysis]
13 Wood SL, Lopez-guajardo A, Brown JE. Identification of new therapeutic targets of bone cancers by proteomic strategies. Bone Cancer 2022. [DOI: 10.1016/b978-0-12-821666-8.00005-0] [Reference Citation Analysis]
14 Çelebioğlu EC, Bilgiç S, Merter A, Karaca MO, Başarır K, Yıldız HY. Scheduling surgery after transarterial embolization: does timing make any difference to intraoperative blood loss for renal cell carcinoma bone metastases? Diagn Interv Radiol 2021;27:740-5. [PMID: 34792028 DOI: 10.5152/dir.2021.21011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Brozovich A, Garmezy B, Pan T, Wang L, Farach-Carson MC, Satcher RL. All bone metastases are not created equal: Revisiting treatment resistance in renal cell carcinoma. J Bone Oncol 2021;31:100399. [PMID: 34745857 DOI: 10.1016/j.jbo.2021.100399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mohakud S, Tripathy S, Bag ND, Mishra N. Multidisciplinary management of solitary hypervascular metastatic recurrence of renal cell carcinoma presenting with pathological femoral fracture. BMJ Case Rep 2021;14:e245422. [PMID: 34753726 DOI: 10.1136/bcr-2021-245422] [Reference Citation Analysis]
17 Haroon M, Sathiadoss P, Hibbert RM, Jeyaraj SK, Lim C, Schieda N. Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma. Abdom Radiol (NY) 2021;46:5386-407. [PMID: 34245341 DOI: 10.1007/s00261-021-03178-6] [Reference Citation Analysis]
18 Boo S, Saad A, Khan Z, Davies AM, James SL, Botchu R. Tumors of the Acromion Process—A Pictorial Review. Indian J Radiol Imaging 2022;31:850-7. [DOI: 10.1055/s-0041-1735916] [Reference Citation Analysis]
19 Facchini G, Parmeggiani A, Peta G, Martella C, Gasbarrini A, Evangelisti G, Miceli M, Rossi G. The role of percutaneous transarterial embolization in the management of spinal bone tumors: a literature review. Eur Spine J 2021;30:2839-51. [PMID: 34415449 DOI: 10.1007/s00586-021-06963-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
20 Zoccali C, Baldi J, Attala D, Scotto di Uccio A, Cannavò L, Scotto G, Luzzati A. 3D-Printed Titanium Custom-Made Prostheses in Reconstruction after Pelvic Tumor Resection: Indications and Results in a Series of 14 Patients at 42 Months of Average Follow-Up. J Clin Med 2021;10:3539. [PMID: 34441834 DOI: 10.3390/jcm10163539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Desai K, Brown L, Wei W, Tucker M, Kao C, Kinsey E, Rini B, Beckermann K, Zhang T, Ornstein MC. A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab. Target Oncol 2021. [PMID: 34379283 DOI: 10.1007/s11523-021-00832-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Młodożeniec P, Balawender K, Zasadny M. Metastatic Lesion of the Tibia from Renal Cell Carcinoma. Case Rep Oncol Med 2021;2021:2428820. [PMID: 34373797 DOI: 10.1155/2021/2428820] [Reference Citation Analysis]
23 Fan Z, Huang Z, Huang X. Bone Metastasis in Renal Cell Carcinoma Patients: Risk and Prognostic Factors and Nomograms. J Oncol 2021;2021:5575295. [PMID: 34054954 DOI: 10.1155/2021/5575295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Wang K, Wu Z, Wang G, Shi H, Xie J, Yin L, Xu T, Mao W, Peng B. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study. Int Braz J Urol 2021;47:333-49. [PMID: 33284535 DOI: 10.1590/S1677-5538.IBJU.2020.0195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
25 Gong D, Sun Y, Guo C, Sheu TJ, Zhai W, Zheng J, Chang C. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis. Clin Transl Med 2021;11:e353. [PMID: 33783995 DOI: 10.1002/ctm2.353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
26 Liu B, Gu X, Sun Q, Jiang S, Sun J, Liu K, Wang F, Wei Y. Injectable In Situ Induced Robust Hydrogel for Photothermal Therapy and Bone Fracture Repair. Adv Funct Mater 2021;31:2010779. [DOI: 10.1002/adfm.202010779] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 24.0] [Reference Citation Analysis]
27 Ortiz-cruz EJ, Peleteiro-pensado M, Barrientos-ruiz I, Ortiz-hernando R. Pelvic Metastases: Diagnosis and Treatment. Surgery of Pelvic Bone Tumors 2021. [DOI: 10.1007/978-3-030-77007-5_9] [Reference Citation Analysis]
28 Kushchayev SV, Liu JKC, Khan M, Arrington JA. Malignant Spinal Osseous Lesions and Vertebral Augmentation. Image Guided Interventions of the Spine 2021. [DOI: 10.1007/978-3-030-80079-6_11] [Reference Citation Analysis]
29 Nieder C, Dalhaug A, Pawinski AR. Management of Patients With Metastatic Renal Cell Cancer and Bone Metastases. In Vivo 2020;34:675-8. [PMID: 32111768 DOI: 10.21873/invivo.11822] [Reference Citation Analysis]
30 Dutcher JP, Flippot R, Fallah J, Escudier B. On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment-Cytokines, Targeted Therapy, and Immunotherapy. Am Soc Clin Oncol Educ Book 2020;40:1-18. [PMID: 32243201 DOI: 10.1200/EDBK_280817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Kang M, Choi J, Kim J, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Park SH, Song C, Seo SI. Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis. J Cancer 2020;11:7202-8. [PMID: 33193883 DOI: 10.7150/jca.48062] [Reference Citation Analysis]
32 Dreyfuss LD, Master VA, Raman JD, Spiess PE, Wells SA, Merrill SB, Peyton CC, Sankar D, Sohl B, Patil D, Shapiro DD, Allen GO, Abel EJ. Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma. Urology 2020;146:152-7. [PMID: 32781079 DOI: 10.1016/j.urology.2020.07.045] [Reference Citation Analysis]
33 Conti A, Bertolo F, Boffano M, Pellegrino P, Ratto N, Piana R. Pathological hip fracture in the elderly: review and proposal of an algorithm. Lo Scalpello 2020;34:128-136. [DOI: 10.36149/0390-5276-160] [Reference Citation Analysis]
34 Dong Y, Wang Z, Lu X, Wu Z, Zhang Z, Yu Y, Peng F, Liu B, Wang L. Clinical outcomes of 168 Chinese patients after local surgery for bone metastases arising from advanced renal cell carcinoma. Cancer 2020;126 Suppl 9:2079-85. [PMID: 32293722 DOI: 10.1002/cncr.32800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 He A, He S, Huang C, Chen Z, Wu Y, Gong Y, Li X, Zhou L. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition. Aging (Albany NY) 2020;12:1465-87. [PMID: 31978894 DOI: 10.18632/aging.102694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
36 Wong ECL, Kapoor A. Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma? Transl Oncol 2020;13:241-4. [PMID: 31869748 DOI: 10.1016/j.tranon.2019.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
37 Dibble EH, Kravets S, Cheng S, Sakellis C, Gray KP, Abbott A, Bossé D, Pomerantz MM, Mcgregor BA, Harshman LC, Michaelson MD, Mckay RR, Choueiri TK, Krajewski KM, Jacene HA. Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and 99mTc-MDP Bone Scan in a Prospective Clinical Trial. KCA 2019;3:241-51. [DOI: 10.3233/kca-190075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Ruatta F, Albiges L, Derosa L. Renal Cell Carcinoma with bone metastases isn't always bad. Oncotarget 2019;10:4511-2. [PMID: 31360299 DOI: 10.18632/oncotarget.27076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Apollonio G, Raimondi A, Verzoni E, Claps M, Sepe P, Pagani F, Ratta R, Montorsi F, De Braud FGM, Procopio G. The role of metastasectomy in advanced renal cell carcinoma. Expert Review of Anticancer Therapy 2019;19:603-11. [DOI: 10.1080/14737140.2019.1625772] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
40 Lu B, Zhu DY, Yin JH, Xu H, Zhang CQ, Ke QF, Gao YS, Guo YP. Incorporation of cerium oxide in hollow mesoporous bioglass scaffolds for enhanced bone regeneration by activating the ERK signaling pathway. Biofabrication 2019;11:025012. [PMID: 30754024 DOI: 10.1088/1758-5090/ab0676] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
41 Boulanger L, Gérard E, Curien R. Multiple gingival metastasis of renal cell carcinoma: a case report. J Oral Med Oral Surg 2019;25:15. [DOI: 10.1051/mbcb/2018037] [Reference Citation Analysis]
42 Choi R, Yu JB. Radiation Therapy for Renal Cell Carcinoma. KCA 2019;3:1-6. [DOI: 10.3233/kca-180040] [Reference Citation Analysis]
43 Dutcher JP. Update on the biology and management of renal cell carcinoma. J Investig Med 2019;67:1-10. [PMID: 30455223 DOI: 10.1136/jim-2018-000918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]